Home / Market News / $USPH
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

Barrington Research Raises Price Target on U.S. Physical Therapy to $110

Nov 7, 2026, 2:06 PM UTC · Primary ticker $USPh

Barrington Research has increased its price target for U.S. Physical Therapy (USPh) to $110 from $98, while maintaining an 'Outperform' rating. This indicates a positive analyst sentiment and could lead to short-term upward pressure on the stock.

Barrington Research updated its outlook on U.S. Physical Therapy, Inc., raising its price target to $110 from $98 and reaffirming an 'Outperform' rating. This action signals increased confidence from a research firm in USPh's future performance and market position. For traders, this could translate into short-term positive momentum for USPh shares as investors react to the upgraded outlook. While not a fundamental change in the company's operations, an analyst upgrade can influence investor perception and trading activity, potentially leading to a modest price increase. The long-term implications depend on whether the company's actual performance validates this increased target.

$USPH positive Analyst price target increase
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.